Navigation Links
Ahram Biosystems Announces Launch of the Palm PCR(TM) Portable PCR System
Date:4/18/2011

SUNNYVALE, Calif., April 18, 2011 /PRNewswire/ -- Ahram Biosystems, Inc., a leading innovator of new life science tools, today announced the launch of the Palm PCR system, an innovative portable PCR device that delivers high performance nucleic acid amplification in a small handheld format.

The palm-sized, battery-powered Palm PCR thermocycler represents a major breakthrough in PCR technology that promises to extend the range of applications of this well-established technology beyond its current indoor limitations. Designed for simplicity and robustness, the Palm PCR system delivers fast and efficient amplification of a large variety of targets including very low copy number of human genomic DNA. Its battery-powered automated operation—more than 4 hours of continuous operation on a single battery charge, extremely low power consumption—less than 5 W, and high efficiency make it ideal for both indoor and outdoor applications.

"The Palm PCR system will change the way scientists think about PCR," said Dr. Hyun Jin Hwang, President and CEO of the company. "It is now possible to do PCR anywhere, anytime without giving up reliability and efficiency. Biotechnology is entering, in the same way Information Technology did before, a new era where small-sized mobile instruments delivering high performance and convenience will be the norm."

The Palm PCR system provides both innovators and traditional users with a functional and handy high-tech tool for extraordinary and/or daily PCR applications. The Palm PCR is loaded with fully validated operation protocols (including fast 18 min protocols to slow 39 min protocols) and comes with specially optimized PCR reagents and consumables as well as matching accessories. It is designed to conform to the standard 9 mm-spaced well format to use with a disposable plastic sample tube. Built on company's proprietary technology, the Palm PCR delivers highly accurate and reproducible results with high temperature uniformity (less than +/- 0.1 degrees C). The small footprint and light weight (71 mm x 121 mm x 47 mm or 2.8" x 4.76" x 1.85", 350 g), and authentic portability make dedicated bench space no longer needed; the Palm PCR system will fit on anyone's workspace, even on a small tray inside a car, and it can be stored away when not in use.

The Palm PCR system is available for order from the company's website (www.ahrambio.com) in three colors.

About Ahram Biosystems:

Ahram Biosystems, Inc. is a leading innovator of new life science tools, taking the initiative to bring portable innovation to the biotechnology market. The company provides the innovative portable PCR system, Palm PCR(TM), designed to perform polymerase chain reactions for both indoor and outdoor genetic applications. The company has its headquarters in Seoul, Korea and a subsidiary in Sunnyvale, California. For more information, visit www.ahrambio.com or contact info@ahrambio.com.


'/>"/>
SOURCE Ahram Biosystems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Allen Institute for Brain Science announces first comprehensive gene map of the human brain
2. S.L.E. Lupus Foundation announces new grants to further NYC scientists leadership in lupus research
3. Ennova Direct Announces the Sale of its Consumer Electronics/Computer Peripheral Patent Portfolio
4. Aware, Inc. Announces Resignation of Chief Executive Officer
5. Navy announces 2011 Young Investigator Program Awards
6. Fueling interventional radiology growth: SIR Foundation announces Navilyst Medical Pledge
7. NSF announces new awards that will investigate more efficient ways to harvest sunlight
8. Biophysical Society announces 2011 Student Research Achievement award winners
9. FBI Announces Initial Operating Capability for Next Generation Identification System
10. Advanced Protection Against Document Fraud - ICAP Ocean Tomo Announces Auction of a Counterfeit Document Detection System
11. MiMedx Group, Inc. Announces Release Date for 2010 Fourth Quarter and Full Year Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2016)... Dec 15, 2016 ... Research and Markets has announced the addition of ... The report forecasts the global military biometrics market to ... The report has been prepared based on an in-depth market analysis ... its growth prospects over the coming years. The report also includes a ...
(Date:12/15/2016)... "Increase in mobile transactions is driving the ... market is expected to grow from USD 4.03 billion ... a CAGR of 29.3% between 2016 and 2022. The ... demand for smart devices, government initiatives, and increasing penetration ... is expected to grow at a high rate during ...
(Date:12/8/2016)... 2016  Singulex, Inc., the leader in Next Generation ... a license and supply agreement with Thermo Fisher Scientific, ... Singulex access to Thermo Scientific BRAHMS PCT (Procalcitonin), a ... used to diagnose systemic bacterial infection and sepsis and ... aid in assessing the risk of critically ill patients ...
Breaking Biology News(10 mins):
(Date:1/11/2017)... , ... January 11, 2017 , ... ... scientific grants to ground-breaking microbiome studies. Its most recent microbiome impact grant award ... who will study the effect of long-term use of oral antibiotics, prescribed for ...
(Date:1/11/2017)... , ... January 11, 2017 , ... ... make all the difference when navigating the challenges young businesses face. With the ... the extensive expertise and experience of Geoff DiMasi, Founder and Principal of interactive ...
(Date:1/11/2017)... ... January 11, 2017 , ... Back pain relief technology is now available ... Surgery for positive back pain relief for WAR members. , This spinal restoration platform ... be life changing for millions suffering from chronic back pain. , What A ...
(Date:1/11/2017)... and BENGALURU, India , Jan. ... Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced ... accepted Mylan,s biologics license application (BLA) for MYL-1401O, a ... This product is a proposed biosimilar to branded trastuzumab, ... The anticipated FDA goal date set under the Biosimilar ...
Breaking Biology Technology: